ArticleTranslational cancer research2022

Tumor-treating fields in combination with sorafenib curtails the growth of colorectal carcinoma by inactivating AKT/STAT3 signaling.

Eun Ho Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.